Mon, November 9, 2020
Fri, November 6, 2020
Thu, November 5, 2020
Wed, November 4, 2020
Tue, November 3, 2020
Mon, November 2, 2020

Jeffrey Hung Maintained (ACAD) at Buy with Increased Target to $58 on, Nov 5th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-58-on-nov-5th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jeffrey Hung of Morgan Stanley, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $57 to $58 on, Nov 5th, 2020.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 7 other peers that have a rating on ACAD. Out of the 7 peers that are also analyzing ACAD, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $42 on, Tuesday, July 21st, 2020


These are the ratings of the 6 analyists that currently disagree with Jeffrey


  • Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $65 on, Tuesday, August 25th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $52 on, Thursday, August 6th, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $60 on, Thursday, August 6th, 2020
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $61 on, Tuesday, July 21st, 2020
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Tuesday, July 21st, 2020
  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $71 on, Tuesday, July 7th, 2020

Publication Contributing Sources